医療用プラスチックコンパウンドの中国市場

【英語タイトル】China Medical Plastic Compounds Market

QYResearchが出版した調査資料(RG-B44861-CN)・商品コード:RG-B44861-CN
・発行会社(調査会社):QYResearch
・発行日:2020年6月
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:中国
・産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,400 ⇒換算¥360,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,100 ⇒換算¥540,600見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD6,800 ⇒換算¥720,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Medical Plastic Compounds market is segmented by Type, and by Application. Players, stakeholders, and other participants in the China Medical Plastic Compounds market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type, and by Application for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Medical Plastic Compounds market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Segment by Type
 Polyvinylchloride
 Polyethylene
 Polypropylene
 Polystyrene
 Polyester
 Polycarbonate
 Polyurethane
 Acrylics
 Others

Segment by Application
 Disposables
 Catheters
 Surgical Instruments
 Medical Bags
 Implants
 Drug Delivery System

By Company
 Kingfa
 Dawn Polymer
 CGN
 GW Plastics
 Baxter International
 Becton & Dickinson
 ExxonMobil Corporation
 Du Pont
 Viant Medical
 Rochling Group
 Nolato AB
 Saint Gobain Performance Plastics.
 Dahai Plastic

【レポートの目次】

1 STUDY COVERAGE
1.1 Medical Plastic Compounds Product Introduction
1.2 Market by Type
1.2.1 China Medical Plastic Compounds Market Size Growth Rate by Type
1.2.2 Polyvinylchloride
1.2.3 Polyethylene
1.2.4 Polypropylene
1.2.5 Polystyrene
1.2.6 Polyester
1.2.7 Polycarbonate
1.2.8 Polyurethane
1.2.9 Acrylics
1.2.10 Others
1.3 Market by Application
1.3.1 China Medical Plastic Compounds Market Size Growth Rate by Application
1.3.2 Disposables
1.3.3 Catheters
1.3.4 Surgical Instruments
1.3.5 Medical Bags
1.3.6 Implants
1.3.7 Drug Delivery System
1.4 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.4.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.4.2 Covid-19 Impact: Commodity Prices Indices
1.4.3 Covid-19 Impact: Global Major Government Policy
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 China Medical Plastic Compounds Revenue Estimates and Forecasts 2015-2026
2.2 China Medical Plastic Compounds Production Capacity Estimates and Forecasts 2015-2026
2.3 China Medical Plastic Compounds Production Estimates and Forecasts 2015-2026
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.4.2 China Medical Plastic Compounds Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4.3 China Medical Plastic Compounds Manufacturers Geographical Distribution
2.5 Key Trends for Medical Plastic Compounds Markets & Products
2.6 Primary Interviews with Key Medical Plastic Compounds Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 China Top Medical Plastic Compounds Manufacturers by Production Capacity
3.1.1 China Top Medical Plastic Compounds Manufacturers by Production Capacity (2015-2020)
3.1.2 China Top Medical Plastic Compounds Manufacturers by Production (2015-2020)
3.1.3 China Top Medical Plastic Compounds Manufacturers Market Share by Production
3.2 China Top Medical Plastic Compounds Manufacturers by Revenue
3.2.1 China Top Medical Plastic Compounds Manufacturers by Revenue (2015-2020)
3.2.2 China Top Medical Plastic Compounds Manufacturers Market Share by Revenue (2015-2020)
3.2.3 China Top 10 and Top 5 Companies by Medical Plastic Compounds Revenue in 2019
3.3 China Medical Plastic Compounds Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 China Medical Plastic Compounds Market Size by Type (2015-2020)
4.1.1 China Medical Plastic Compounds Production by Type (2015-2020)
4.1.2 China Medical Plastic Compounds Revenue by Type (2015-2020)
4.1.3 Medical Plastic Compounds Price by Type (2015-2020)
4.2 China Medical Plastic Compounds Market Forecast by Type (2021-2026)
4.2.1 China Medical Plastic Compounds Production Forecast by Type (2021-2026)
4.2.2 China Medical Plastic Compounds Revenue Forecast by Type (2021-2026)
4.2.3 China Medical Plastic Compounds Price Forecast by Type (2021-2026)
4.3 China Medical Plastic Compounds Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 MARKET SIZE BY APPLICATION
5.1 China Medical Plastic Compounds Consumption Historic Breakdown by Application (2015-2020)
5.2 China Medical Plastic Compounds Consumption Forecast by Application (2021-2026)
6 CORPORATE PROFILE
6.1 Kingfa
6.1.1 Kingfa Corporation Information
6.1.2 Kingfa Business and Overview
6.1.3 Kingfa Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.1.4 Kingfa Medical Plastic Compounds Product Description
6.1.5 Kingfa Recent Development
6.2 Dawn Polymer
6.2.1 Dawn Polymer Corporation Information
6.2.2 Dawn Polymer Business and Overview
6.2.3 Dawn Polymer Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.2.4 Dawn Polymer Medical Plastic Compounds Product Description
6.2.5 Dawn Polymer Recent Development
6.3 CGN
6.3.1 CGN Corporation Information
6.3.2 CGN Business and Overview
6.3.3 CGN Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.3.4 CGN Medical Plastic Compounds Product Description
6.3.5 CGN Recent Development
6.4 GW Plastics
6.4.1 GW Plastics Corporation Information
6.4.2 GW Plastics Business and Overview
6.4.3 GW Plastics Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.4.4 GW Plastics Medical Plastic Compounds Product Description
6.4.5 GW Plastics Recent Development
6.5 Baxter International
6.5.1 Baxter International Corporation Information
6.5.2 Baxter International Business and Overview
6.5.3 Baxter International Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.5.4 Baxter International Medical Plastic Compounds Product Description
6.5.5 Baxter International Recent Development
6.6 Becton & Dickinson
6.6.1 Becton & Dickinson Corporation Information
6.6.2 Becton & Dickinson Business and Overview
6.6.3 Becton & Dickinson Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.6.4 Becton & Dickinson Medical Plastic Compounds Product Description
6.6.5 Becton & Dickinson Recent Development
6.7 ExxonMobil Corporation
6.7.1 ExxonMobil Corporation Corporation Information
6.7.2 ExxonMobil Corporation Business and Overview
6.7.3 ExxonMobil Corporation Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.7.4 ExxonMobil Corporation Medical Plastic Compounds Product Description
6.7.5 ExxonMobil Corporation Recent Development
6.8 Du Pont
6.8.1 Du Pont Corporation Information
6.8.2 Du Pont Business and Overview
6.8.3 Du Pont Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.8.4 Du Pont Medical Plastic Compounds Product Description
6.8.5 Du Pont Recent Development
6.9 Viant Medical
6.9.1 Viant Medical Corporation Information
6.9.2 Viant Medical Business and Overview
6.9.3 Viant Medical Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.9.4 Viant Medical Medical Plastic Compounds Product Description
6.9.5 Viant Medical Recent Development
6.10 Rochling Group
6.10.1 Rochling Group Corporation Information
6.10.2 Rochling Group Business and Overview
6.10.3 Rochling Group Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.10.4 Rochling Group Medical Plastic Compounds Product Description
6.10.5 Rochling Group Recent Development
6.11 Nolato AB
6.11.1 Nolato AB Corporation Information
6.11.2 Nolato AB Business and Overview
6.11.3 Nolato AB Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.11.4 Nolato AB Medical Plastic Compounds Product Description
6.11.5 Nolato AB Recent Development
6.12 Saint Gobain Performance Plastics.
6.12.1 Saint Gobain Performance Plastics. Corporation Information
6.12.2 Saint Gobain Performance Plastics. Business and Overview
6.12.3 Saint Gobain Performance Plastics. Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.12.4 Saint Gobain Performance Plastics. Medical Plastic Compounds Product Description
6.12.5 Saint Gobain Performance Plastics. Recent Development
6.13 Dahai Plastic
6.13.1 Dahai Plastic Corporation Information
6.13.2 Dahai Plastic Business and Overview
6.13.3 Dahai Plastic Medical Plastic Compounds Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
6.13.4 Dahai Plastic Medical Plastic Compounds Product Description
6.13.5 Dahai Plastic Recent Development
7 VALUE CHAIN AND SALES CHANNELS ANALYSIS
7.1 Medical Plastic Compounds Value Chain Analysis
7.2 Medical Plastic Compounds Sales Channels Analysis
7.2.1 Medical Plastic Compounds Sales Channels
7.2.2 Medical Plastic Compounds Distributors
7.3 Medical Plastic Compounds Customers
8 MARKET DYNAMICS
8.1 Medical Plastic Compounds Market Trends
8.2 Medical Plastic Compounds Opportunities and Drivers
8.3 Medical Plastic Compounds Market Challenges
8.4 Medical Plastic Compounds Market Restraints
8.5 Porter’s Five Forces Analysis
9 KEY FINDINGS IN THE CHINA MEDICAL PLASTIC COMPOUNDS STUDY
10 APPENDIX
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer



★調査レポート[医療用プラスチックコンパウンドの中国市場] (コード:RG-B44861-CN)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療用プラスチックコンパウンドの中国市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆